DXS International Plc

DXS International Plc

AAQSE:DXSP
1.50
GBX
-0.18
(-10.71%)
-0.15EPS
128.20MMarket Cap
Jan 27Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.08
0.1
0.11
0.09
0.08
0.07
0.07
0.07
0.08
0.05
0.05
Basic EPS, GAAP
0.01
0.01
0.01
- -
- -
0.01
0.01
0.01
0.01
-0.07
- -
Free Cash Flow per Basic Share
-0.01
- -
- -
-0.01
- -
- -
-0.01
- -
-0.01
-0.01
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.04
0.05
0.06
0.06
0.06
0.08
0.09
0.09
0.1
0.01
0.01
Tangible Book Value per Share
-0.02
-0.01
-0.02
-0.03
-0.04
-0.01
-0.01
-0.02
-0.03
-0.02
-0.02
Basic Weighted Avg Shares
33
31
32
37
43
48
48
44
45
64
64
Sales/Revenue/Turnover
3
3
3
3
3
3
4
3
3
3
3
Operating Margin (%)
2.23
2.18
0.45
-0.46
-4.11
9.27
8.25
-1.69
-1.26
-15.07
-3.7
Depreciation Expense
- -
- -
- -
- -
1
1
1
1
1
5
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
-5
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
11.01
6.73
6.54
4.37
2.54
13.06
13.78
6.77
6.64
-143.23
-2.73
Working Capital
- -
1
1
1
- -
1
1
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Total Equity
1
2
2
2
2
4
4
4
5
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
14.55
12.6
7.57
3.97
14.54
12.74
5.22
5.03
-188.15
-23.42

Capital Structure

GBP

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

GBP

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.26%
-17.08%
-19.17%
Free Cash Flow
-194.13%
-115.11%
-194.86%
Net Income, GAAP
-203.78%
-468.06%
-98%
Sales/Revenue/Turnover
2.72%
1.34%
4.88%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3
2024
- -
- -
3
2025
- -
- -
3

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.01
2024
- -
- -
-0.07
2025
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
David Immelman
Sector
Technology services
Industry
Packaged software
Address
Elstead United Kingdom
IPO Date
Jul 31, 2008
Business
DXS International Plc is a United Kingdom-based healthcare technology company that designs, develops, and distributes clinical decision support systems and digital workflow management software for primary care medical providers. Founded in 1999 and headquartered in Farnham, Surrey, the company operates primarily across the United Kingdom, serving National Health Service general practitioner practices, Integrated Care Boards, Primary Care Networks, and healthcare commissioning bodies through its operating subsidiary, DXS UK Limited. The company’s core product and service portfolio includes DXS Point-of-Care, an electronic clinical decision support platform integrated directly into electronic health record systems such as EMIS Web and TPP SystmOne to provide clinicians with real-time access to localized clinical guidelines, diagnostic pathways, referral forms, and patient information leaflets during consultations; ExpertCare, an automated clinical management and medicine optimization solution designed to assist practitioners in managing chronic conditions such as hypertension and chronic kidney disease through evidence-based treatment recommendations and medication titration protocols; CompleteCare, a clinical review and assessment platform that standardizes chronic disease management workflows and assists medical practices in achieving Quality and Outcomes Framework and Enhanced Services targets; and digital referral management solutions that optimize patient triage, reduce administrative overhead, and facilitate communication between primary and secondary care providers. In recent operational and strategic developments, DXS International has focused on expanding the commercial rollout of its ExpertCare platform across regional Integrated Care Boards to support preventative healthcare and hypertension management programs. The company has also advanced the migration of its core clinical decision support infrastructure to modern cloud-delivered software-as-a-service architectures, deepened technical interoperability with next-generation primary care clinical systems, and aligned its commercial offering with NHS structural reforms to address elective care referral backlogs and enhance regional population health management.